Active Biotech AB publ announced earnings results for the fourth quarter ended December 31, 2019. For the fourth quarter, the company announced sales was SEK 0.9 million compared to SEK 4.8 million a year ago. Operating loss was SEK 11.2 million compared to SEK 7.1 million a year ago. Net loss was SEK 11.2 million compared to SEK 8.9 million a year ago. Basic loss per share was SEK 0.08 compared to SEK 0.06 a year ago. For the full year, sales was SEK 8.4 million compared to SEK 20.1 million a year ago. Operating loss was SEK 32.3 million compared to SEK 29.8 million a year ago. Net loss was SEK 34.1 million compared to SEK 36.9 million a year ago. Basic loss per share was SEK 0.24 compared to SEK 0.27 a year ago.